Literature DB >> 23430800

Differential phonological awareness skills in children with classic galactosemia: a descriptive study of four cases.

Fiona M Lewis1, David J Coman, Maryann Syrmis, Sarah Kilcoyne, Bruce E Murdoch.   

Abstract

Educational achievement, which for individuals with the metabolic disorder classic galactosemia (GAL) is significantly lower than in the wider population, correlates with self-reported quality of life. Phonological awareness skills underpin the development of literacy, and although literacy is a key contributor to successful academic outcomes, no study to date has investigated phonological awareness skills in children with GAL. This study investigated phonological awareness (PA) in four school-aged children with the disorder, two of whom were siblings. Age range for the children was 7 years 7 months to 9 years 2 months. Each child was assessed with the Phonological Awareness criterion-referenced subtest from the Clinical Evaluation of Language Fundamentals-Fourth Edition. Included in the data for analysis was each child's performance measures obtained from their most recent assessment of cognitive and lexical development. A number of descriptive analyses were undertaken on the data. One child, who met her age criterion for PA, had cognitive and lexical development skills in the average range. The remaining three children failed to meet their age criteria. Although these three children presented with clinically similar cognitive and lexical development skills, disparate PA skills were identified. The PA skills of one of the sibling pair were notably more advanced than his older sibling. The limitations of relying on behavioural test results in children with GAL to predict those most at risk of reduced skill development are discussed in terms future research directions.

Entities:  

Year:  2012        PMID: 23430800      PMCID: PMC3755575          DOI: 10.1007/8904_2012_200

Source DB:  PubMed          Journal:  JIMD Rep        ISSN: 2192-8304


  33 in total

1.  Phonological processing, language, and literacy: a comparison of children with mild-to-moderate sensorineural hearing loss and those with specific language impairment.

Authors:  J Briscoe; D V Bishop; C F Norbury
Journal:  J Child Psychol Psychiatry       Date:  2001-03       Impact factor: 8.982

2.  Is there a causal link from phonological awareness to success in learning to read?

Authors:  Anne Castles; Max Coltheart
Journal:  Cognition       Date:  2004-02

3.  The neuropsychological profile of galactosaemia.

Authors:  Claire M Doyle; Shelley Channon; Danuta Orlowska; Philip J Lee
Journal:  J Inherit Metab Dis       Date:  2010-07-06       Impact factor: 4.982

4.  Mealtime talk that supports literacy development.

Authors:  Catherine E Snow; Diane E Beals
Journal:  New Dir Child Adolesc Dev       Date:  2006

Review 5.  Phonological awareness of children with Down syndrome: its role in learning to read and the effectiveness of related interventions.

Authors:  Christopher J Lemons; Douglas Fuchs
Journal:  Res Dev Disabil       Date:  2009-11-30

Review 6.  Classical galactosaemia revisited.

Authors:  Annet M Bosch
Journal:  J Inherit Metab Dis       Date:  2006-07-11       Impact factor: 4.982

7.  A longitudinal study of cognitive functioning in patients with classical galactosaemia, including a cohort treated with oral uridine.

Authors:  F R Manis; L B Cohn; C McBride-Chang; J A Wolff; F R Kaufman
Journal:  J Inherit Metab Dis       Date:  1997-08       Impact factor: 4.982

8.  Effectiveness of Early Phonological Awareness Interventions for Students with Speech or Language Impairments.

Authors:  Stephanie Al Otaiba; Cynthia Puranik; Robin Zilkowski; Tricia Curran
Journal:  J Spec Educ       Date:  2009-08-01

9.  Language and literacy outcomes from a pilot intervention study for children with fetal alcohol spectrum disorders in South Africa.

Authors:  Colleen M Adnams; Pharyn Sorour; Wendy O Kalberg; Piyadasa Kodituwakku; Mariechen D Perold; Anna Kotze; Sean September; Bernice Castle; J Gossage; Philip A May
Journal:  Alcohol       Date:  2007-09       Impact factor: 2.405

Review 10.  Language production and working memory in classic galactosemia from a cognitive neuroscience perspective: future research directions.

Authors:  Inge Timmers; Job van den Hurk; Francesco Di Salle; M Estela Rubio-Gozalbo; Bernadette M Jansma
Journal:  J Inherit Metab Dis       Date:  2011-02-03       Impact factor: 4.982

View more
  4 in total

1.  Translating principles of precision medicine into speech-language pathology: Clinical trial of a proactive speech and language intervention for infants with classic galactosemia.

Authors:  Beate Peter; Jennifer Davis; Lizbeth Finestack; Carol Stoel-Gammon; Mark VanDam; Laurel Bruce; Yookyung Kim; Linda Eng; Sarah Cotter; Emily Landis; Sam Beames; Nancy Scherer; Ina Knerr; Delaney Williams; Claire Schrock; Nancy Potter
Journal:  HGG Adv       Date:  2022-05-20

2.  Classical galactosemia: neuropsychological and psychosocial functioning beyond intellectual abilities.

Authors:  Mendy M Welsink-Karssies; Kim J Oostrom; Merel E Hermans; Carla E M Hollak; Mirian C H Janssen; Janneke G Langendonk; Esmee Oussoren; M Estela Rubio Gozalbo; Maaike de Vries; Gert J Geurtsen; Annet M Bosch
Journal:  Orphanet J Rare Dis       Date:  2020-02-07       Impact factor: 4.123

3.  Toward Preventing Speech and Language Disorders of Known Genetic Origin: First Post-Intervention Results of Babble Boot Camp in Children With Classic Galactosemia.

Authors:  Beate Peter; Jennifer Davis; Sarah Cotter; Alicia Belter; Emma Williams; Melissa Stumpf; Laurel Bruce; Linda Eng; Yookyung Kim; Lizbeth Finestack; Carol Stoel-Gammon; Delaney Williams; Nancy Scherer; Mark VanDam; Nancy Potter
Journal:  Am J Speech Lang Pathol       Date:  2021-10-19       Impact factor: 4.018

4.  Cognitive functioning in patients with classical galactosemia: a systematic review.

Authors:  Merel E Hermans; Mendy M Welsink-Karssies; Annet M Bosch; Kim J Oostrom; Gert J Geurtsen
Journal:  Orphanet J Rare Dis       Date:  2019-10-18       Impact factor: 4.123

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.